Utama › Kanser Paru-paru Sel Kecil › Illinois › Chicago
Kajian klinikal Kanser Paru-paru Sel Kecil di Chicago, IL
12 kajian untuk Kanser Paru-paru Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- University of Chicago Medical Center /ID# 280149, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- Northwestern University Feinberg School of Medicine, Chicago
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
Mengambil pesertaFasa 1/2
- University of Chicago ( Site 1108), Chicago
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
Mengambil pesertaFasa 2
- Northwestern, Chicago
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Rush MD Anderson Cancer Center, Chicago
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Mengambil pesertaFasa 1
- University of Illinois Chicago, Chicago
Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer
Mengambil pesertaFasa 2
- University of Illinois Chicago, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- The University of Chicago Medical Center (UCMC), Chicago
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Mengambil pesertaFasa 2
- University of Illinois Cancer Center, Chicago
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Mengambil pesertaFasa 2
- Northwestern University, Chicago
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Mengambil pesertaFasa 1/2
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
Mengambil pesertaFasa 2
- University of Chicago Medicine, Chicago
Kajian Kanser Paru-paru Sel Kecil di bandar lain
- Houston, TX26 kajian
- Arlington, VA23 kajian
- Boston, MA21 kajian
- New York City, NY21 kajian
- Nashville, TN20 kajian
- Los Angeles, CA20 kajian
- Orlando, FL15 kajian
- Dallas, TX13 kajian
- St. Louis, MO13 kajian
- Cleveland, OH13 kajian
- Detroit, MI12 kajian
- Washington, DC12 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kanser Kolorektal33 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.